

ADARx Pharmaceuticals Inc (ADRX)
Order type
Buy in
Order amount
Est. shares
0 shares
Buy ADRX Stock
Start investing in ADRX
About ADARx Pharmaceuticals Inc (ADRX)
| Market cap | $1.65B |
| Yesterday's volume | 994.95K |
| Revenue (TTM) | — |
| Avg. daily volume | 633.48K |
| EBITDA (TTM) | — |
| Open | $13.25 |
| Price / earnings ratio | — |
| Yesterday's range | $12.87 - $16.24 |
| Debt / equity | 0.06x |
| 52 week range | $12.5 - $23.21 |
| 5 year debt / equity | 0.03x |
| Beta (LTM) | 1.47x |
| Interest coverage | — |
| Dividend & yield | $0.00 (0.00%) |
| Current ratio | 12.98x |
| Ex-dividend date | |
| Next earnings | |
| Dividend payable date |
ADRX Stock Rating
ADRX Stock News




Frequently Asked Questions (FAQ)
How to buy ADRX stock on Public
- 1
Sign up for a brokerage account on Public
It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.
- 2
Add funds to your Public account
There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.
- 3
Choose how much you'd like to invest in ADRX stock
Navigate to the Explore page. Then, type ADRX into the search bar. When you see ADRX stock appear in the results, tap it to open up the purchase screen.
- 4
Manage your investments in one place
You can find your newly purchased ADRX stock in your portfolio alongside the rest of your stocks, ETFs, crypto, bonds, options, and your high-yield cash account––all in one place on Public.
ADARx Pharmaceuticals Inc Stock Earnings
The value each ADRX share was expected to gain vs. the value that each ADRX share actually gained.
ADRX (ADRX) reported Q3 2026 earnings per share (EPS) of -$1.74, missing estimates of -$0.37 by 370.27%. In the same quarter last year, ADRX's earnings per share (EPS) was $0. ADRX is expected to release next earnings on , with an earnings per share (EPS) estimate of $0.
Buy ADRX Stock
Start investing in ADRX
Order type
Buy in
Order amount
Est. shares
0 shares